Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Cancer

‘Every patient is different’: why inclusivity is at the heart of Sheffield Hallam’s healthcare courses

When students are trained to recognise diversity and offer personalised care, it results in better health outcomes for the communities they go on to serve. At Sheffield Hallam University, that ethos is powering the next generation of healthcare professionals

The Guardian - UK

Could a Blood Test Predict Cancer Before Symptoms Appear?

Lung cancer is often called the silent killer. By the time symptoms appear, the disease has usually advanced, making treatment more difficult and survival chances lower. For decades, doctors have searched for a way to identify risk before cancer takes hold. Now, scientists may have found one. A groundbreaking study…

MyLifeXP

Coronation Street star Tracy Shaw 'vulnerable as a baby' after A&E trip over horrific chemo side effect

The 52-year-old said she ‘has no strength left’ after being diagnosed with breast cancer in April

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

AAP Rolling News Bulletin June 8, 1900

AAP Rolling News Bulletin for June 8 at 1900

AAP

Weight loss jabs linked to dramatic fall in obesity cancer risk

IN FULL

The Independent UK

Monday briefing: Are we any closer to a cure for cancer?

In today’s newsletter: Researchers are giving us new insights into early detection and treatments, but with access to life-saving care remaining uneven patients still have a long road ahead

The Guardian - UK

Kiran Mazumdar-Shaw's Immuneel Therapeutics raises Rs 100 crore from Singularity AMC, Rainmatter, others

The Bengaluru-based company makes CAR-T therapy, a form of cancer treatment where a patient’s own immune cells are taken out, trained in a lab to fight cancer, and then put back into the body. The treatment has been seen as a major breakthrough globally, but has remained out of reach…

The Economic Times

Read news from The Economist, FT, and more,
with one subscription

FED:Pioneering researcher remembered as cancer fight ends

A renowned pathologist and former Australian of the Year has been remembered as a selfless fighter who strived to improve the lives of others.

AAP

FED:State funeral for research pioneer as cancer fight ends

"Remarkable" melanoma pathologist and former Australian of the Year Richard Scolyer, who died from brain cancer aged 59, will have a state funeral.

AAP

Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance

SHANGHAI and HONG KONG, June 8, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune diseases, solid tumors and hematological malignancies indications, today announced that it has presented the first…

AAP

Chris Hoy on redefining late-stage cancer: ‘There’s plenty of life left in us’

Speaking to the Press Association on Friday, Sir Chris Hoy said he was ‘doing fine’.

Evening Standard

Experts call for weight loss jabs to be investigated as cancer prevention

Experts from the US examined data on more than 161,000 patients

The Independent UK

Richard Scolyer leaves a unique legacy of pioneering brain cancer research

Professor Richard Scolyer, renowned pathologist and joint Australian of the Year (2024), has died at the age of 59.

The Conversation

FED:Scientist Richard Scolyer dies after cancer battle

World-renowned melanoma pathologist and former Australian of the Year Richard Scolyer has died from brain cancer aged 59.

AAP

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

CG Oncology Touts Cretostimogene Data, BLA Progress in Bladder Cancer Push

CG Oncology (NASDAQ:CGON) is focused on advancing cretostimogene, an oncolytic immunotherapy for non-muscle invasive bladder cancer, Chief Executive Officer Arthur Kuan said during a discussion at the Jefferies Global Healthcare Conference in New York. Kuan said the company believes the therapy cou

The Guardian - AU

Richard Scolyer, acclaimed melanoma researcher who tried experimental treatment on his own brain cancer – obituary

Pathologist and athlete who was Australian of the year in 2024 underwent a bold experimental treatment after devastating brain cancer diagnosis

The Guardian - AU

Richard Scolyer, cancer researcher and former Australian of the year, dies aged 59

Scolyer, who did pioneering work on immunotherapy, was diagnosed with inoperable brain cancer in 2023

The Guardian - UK

The Guardian view on cancer treatments: new hope for patients now and in the future

Editorial: A drug for pancreatic cancer shows immense promise, but we shouldn’t forget research in the field is a story of small victories

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

NHS hospitals adopt faster, more accurate at-home bladder cancer test

Five hospitals in England and Wales have switched to urine test, rather than invasive hospital procedure

AAP

Lauded cancer doctor dies, leaving scientific legacy

Professor Richard Scolyer was a joint Australian of the Year for research into melanoma treatment before developing techniques to fight his own brain cancer.

AAP

FED:Renowned doctor Scolyer dies after public cancer battle

Renowned melanoma pathologist and father of three Richard Scolyer has died at the age of 59.

AAP

Pioneering researcher remembered as cancer fight ends

A renowned pathologist and former Australian of the Year has been remembered as a selfless fighter who strived to improve the lives of others.

Medical Daily

Penn Medicine Reports 30% Drop in Breast Cancer Risk with Ozempic and Wegovy

Penn Medicine researchers report a 30% lower breast cancer risk in women using Ozempic and Wegovy, based on a study of 111,646 patients. Findings suggest GLP-1 drugs may play a role in cancer prevention, though experts stress results are observational.

International Business Times UK

Cancer Patients Must Now Prove They Are Too Ill to Work or Lose Their Medicaid Coverage Under New Trump Rules

A new Medicaid rule requires cancer patients to prove severe illness to maintain coverage, sparking backlash from patient advocates who argue it imposes undue burdens on seriously ill individuals.

The Times of India

A billionaire family gave $100 million so cancer researchers could stop working in silos

A groundbreaking $200 million initiative, the Weill Cancer Hub West, is uniting Stanford and UCSF to foster unprecedented collaboration in cancer research. This ten-year program, backed by the Weill Family Foundation, aims to break down institutional barriers, encouraging joint projects and shared infrastructure.

1 … 20 21 22 23

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Press Association

171 stories

the University of Sydney

Sheffield Hallam University

Weill Cornell Medicine

19 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.